Trial
NCT05157464
Losartan Use to Mitigate Arthrofibrosis Following Total Join Arthroplasty
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
NYU Langone Health
Collaborators
—
Condition
Arthrofibrosis
Intervention
Losartan
Why stopped
Study was not initiated, no participants enrolled.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-12-01